The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is ...

A devastating bus accident in Saudi Arabia has claimed the lives of 42 Indian Umrah pilgrims traveling from Mecca to Medina. The passenger bus collided with a diesel tanker, with preliminary reports ...

The Telangana Chief Minister's office released a set of helpline numbers to provide information to the families and relatives of those involved in the bus accident that took place in Saudi Arabia on ...

A tragic bus accident near Medina, Saudi Arabia, claimed the lives of 42 Indian Umrah pilgrims, many believed to be from Hyderabad. The bus collided with a diesel tanker while traveling from Mecca.

According to Windows Latest, popular messaging service WhatsApp is downgrading its Windows 11 app to a WebView2 equivalent in the latest update, switching from a native Windows application to a web ...

OpenAI said Tuesday it is introducing its own web browser, Atlas, putting the ChatGPT maker in direct competition with Google as more internet users rely on artificial intelligence to answer their ...

A national group fighting gambling addiction lost control of the 1-800-GAMBLER helpline on Monday after a New Jersey court agreed to give it back to a locally run nonprofit, which first launched the ...

Dedicated servers are vital hosting platforms for resource-intensive online businesses. These tested, top-rated web hosts deliver the reliability and power that mission-critical websites demand. Web ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

The tutorial of Elden Ring Nightreign has players fighting the Fell Omen. Many will fall to this boss, unable to beat it. But that begs the question: What do you get if you beat the Fell Omen in the ...

ADELA: A double-blind, placebo-controlled, randomized phase 3 trial of elacestrant (ELA) + everolimus (EVE) versus ELA + placebo (PBO) in ER+/HER2- advanced breast cancer (aBC) patients with ...